Global Diabetes Devices Market And Diabetes Drugs Market Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018 This report is an effort to identify factors, which will be the driving force behind the diabetes devices and drugs market and sub-markets in the next few years. The report provides extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the diabetes devices and drugs industry in terms of product and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global diabetes devices and drugs market and further validated numbers with the key market participants and C-level executives. This report highlights the industry with the following points: Definition, estimates & forecast of diabetes devices and drugsproduct market from 2010 to 2018 Analysis of product segments for diabetes devices and drugs product market with historical data and forecast Trends and forecast for four geographic markets, namely the U.S., Europe, Asia-Pacific, Middle East and Africa and Latin America based on segments of diabetes devices and drugs product market Profiles of major market participants for better understanding of their contributions This research is specially designed to estimate and analyze the demand and performance of diabetes devices and drugs products in a global scenario. The research provides in-depth analysis of diabetes devices and drugs product manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global diabetes devices and drugs market, and provide historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global diabetes devices and drugs market as below: Diagnosis and Monitoring Devices Market Blood Glucose Monitoring Devices LancetsBlood Sampling DevicesBlood Glucose MetersNew Development in Glucose Testing Other Testing Devices Hemoglobin A1cHemoglobin A1c MetersHemoglobin A1c Kits Others Software Programs for Diabetes MonitoringWeb SoftwareCommercial SoftwareArtificial Pancreas Therapeutics Devices and Drugs Market Insulin By Action Short ActingPre-MixesLong Acting By Type Human InsulinModern InsulinAnimal Insulin By Purchase Type DosageBulk Insulin Delivery SyringesPensInjectorsInhaled InsulinInsulin Pumps Oral Hypoglycemic Agents KATP Blocker BiguanidesAlpha-Glucosidase Inhibitor Thiazolinediones/ GlitazonesIncretinMimetics/ GLP-1 Analogs DPP-4 Inhibitors Amylin Mimetic SGLT2 InhibitorsOther Cell Therapies In addition the report provides a cross-sectional analysis of all the above segments with respect to following geographical markets: North America Asia-Pacific Middle East and Africa The in-depth research and high level analysis will allow diabetes devices and drugs product manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about diabetes devices and drugs products manufacturing, designing marketing, growth strategies and gaining competitive advantage.? 3.6.1.1 Growing Diabetic Population around the Globe 3.6.1.2 Changing Lifestyle and Obesity as a Leading Cause of Diabetes 3.6.1.3 Launch of New Generation Innovative Drugs Likely to Attract Consumers 3.6.2.1 Lack of Awareness about Diabetes Diagnostics and Treatment 3.6.2.2 Adverse side-effects of drugs and the resulting litigation issues 3.6.3.1 Increasing Awareness may Unleash the Untapped Market CHAPTER 4 GLOBAL DIABETES DEVICES AND DRUGS MARKET4.1 GLOBAL DIABETES DIAGNOSIS AND MONITORING DEVICES MARKET SIZE AND FORECAST, BY TYPE2010 - 20184.1.1 BLOOD GLUCOSE MONITORING DEVICES, MARKET SIZE AND FORECAST4.1.1.1 Lancets4.1.1.2 Blood Sampling Devices4.1.1.3 Blood Glucose Monitors4.1.1.3.1 Drivers4.1.1.3.1.1 Increasing awareness and simpler devices4.1.1.3.1.2 Increase in disposable income4.1.1.3.1.3 Declining prices4.1.1.3.1.4 Improving compatibility4.1.1.3.2 Restraints4.1.1.3.2.1 Increase in competition leading to low prices4.1.1.3.2.2 Private label brands4.1.1.3.2.3 Awareness among patients is still a challenge4.1.1.3.3 Key trends4.1.1.4 New Development in Glucose Testing4.1.2 OTHER TESTING DEVICES MARKET SIZE AND FORECAST4.1.2.1 Hemoglobin A1c4.1.2.1.1 Hemoglobin A1c Meters4.1.2.1.2 Hemoglobin A1c Kits4.1.2.2 Others4.1.3 SOFTWARE PROGRAMS FOR DIABETES MONITORING, MARKET SIZE AND FORECAST4.1.3.1 Web Software Programs for Diabetes Monitoring4.1.3.2 Commercial Software4.1.4 ARTIFICIAL PANCREAS, MARKET SIZE AND FORECAST4.2 GLOBAL DIABETES THERAPEUTICS DEVICES AND DRUGS MARKET SIZE AND FORECAST, BY TYPE, 2011 - 20184.2.1 DRIVERS4.2.1.1 Improved Delivery Devices4.2.1.2 Increased Risk with Oral Anti-Diabetes Drugs4.2.1.3 Technological Advancement4.2.2 RESTRAINTS4.2.2.1 Associated Pain4.2.2.2 Market boom for New Generation diabetic drugs4.2.2.3 Cost Issues4.2.3 OPPORTUNITIES4.2.3.1 Novel insulin delivery method4.2.4 GLOBAL ORAL DIABETES DRUG MARKET4.2.4.1 Popular Anti-Diabetic Drugs World wide4.2.4.2 Drivers4.2.4.2.1 Novel drugs driving the market growth4.2.4.2.2 Patent expiry of popular drugs4.2.4.2.3 Painless Option4.2.5 RESTRAINTS4.2.5.1 Associated high risks4.2.5.2 Improving options of insulin delivery devices4.2.5.3 Trend of diabetic diet4.2.6 OPPORTUNITIES4.2.6.1 Diabetes Vaccines4.2.6.2 Leveraging the patent expiry of popular drugs4.2.7 INSULIN, MAKET SIZE AND FORECAST 4.2.7.1 Market Size and Forecast4.2.7.2 Global Insulin Market Share of Major Players, 2011 4.2.7 2.1 Global Human Insulin Market Share of Major Players, 2011 4.2.7 2.2 Global Modern Insulin Market Share of Major Players, 20114.2.7.3 Insulin Market Size and Forecast, By Action4.2.7.3.1 Short Acting4.2.7.3.2 Pre-Mixes4.2.7.3.3 Long Acting4.2.7.4 Insulin Market Size and Forecast, by Type4.2.7.4.1 Human Insulin4.2.7.4.2 Modern Insulin4.2.7.4.3 Animal Insulin4.2.7.5 Insulin Market Size and Forecast, by Purchase Type4.2.7.5.1 Dosage4.2.7.5.2 Bulk4.2.8 INSULIN, DELIVERY MAKET SIZE AND FORECAST4.2.8.1 Insulin Syringes Maket Size and Forecast 4.2.8.2 Insulin Pens Maket Size and Forecast4.2.8.3 Insulin Injectors Maket Size and Forecast 4.2.8.4 Inhaled Insulin Maket Size and Forecast 4.2.8.5 Insulin Pumps Maket Size and Forecast 4.2.8.5.1 Drivers4.2.8.5.1.1 Growing Diabetic Population4.2.8.5.1.2 Advancement in Technology4.2.9 ORAL HYPOGLYCEMIC AGENTS, MAKET SIZE AND FORECAST4.2.9.1 KATP Blocker Maket Size and Forecast4.2.9.2 Biguanides Maket Size and Forecast 4.2.9.3 Alpha-Glucosidase Inhibitor Maket Size and Forecast 4.2.9.4 Thiazolinediones/ Glitazones Maket Size and Forecast 4.2.9.5 Incretin Mimetics/ GLP-1 Analogs Maket Size and Forecast 4.2.9.6 DPP-4 InhibitorMaket Size and Forecast 4.2.9.7 Amylin Mimetic Maket Size and Forecast 4.2.9.8 SGLT2 Inhibitors Maket Size and Forecast 4.2.9.9 Other Oral Hypoglycemic Agents Maket Size and Forecast 4.2.10 CELL THERAPIES MAKET SIZE AND FORECAST 5.2.1.1 Undiagnosed patients high in European countries 5.2.1.2 Increasing R&D costs 5.2.2.1 Case1 5.2.2.2 Case 2 5.2.2.3 Case 3 5.2.3.1 Undiagnosed Diabetic Patient Population in Europe 5.2.5.1 Blood glucose monitoring devices, maket size and forecast 5.2.5.2 Other dibetes testing devices, maket size and forecast 5.2.5.3 Software programs for diabetes monitoring, maket size and forecast 5.2.5.4 Artificial pancreas, maket size and forecast 5.2.6.1 Insulin, maket size and forecast 5.2.6.2 Insulin delivery, maket size and forecast 5.2.6.3 Oral hypoglycemic agents, maket size and forecast 5.2.6.4 Cell therapies, maket size and forecast 5.3.5.1 Blood glucose monitoring devices, maket size and forecast 5.3.5.2 Other dibetes testing devices, maket size and forecast 5.3.5.3 Software programs for diabetes monitoring, maket size and forecast 5.3.5.4 Artificial pancreas, maket size and forecast 5.3.6.1 Insulin, maket size and forecast 5.3.6.2 Insulin delivery, maket size and forecast 5.3.6.3 Oral hypoglycemic agents, maket size and forecast 5.3.6.4 Cell therapies, maket size and forecast 5.4.1.1 Blood glucose monitoring devices, maket size and forecast 5.4.1.2 Other dibetes testing devices, maket size and forecast 5.4.1.3 Software programs for diabetes monitoring, maket size and forecast 5.4.1.4 Artificial pancreas, maket size and forecast 5.4.2.1 Insulin, maket size and forecast 5.4.2.2 Insulin delivery, maket size and forecast 5.4.2.3 Oral hypoglycemic agents, maket size and forecast 5.4.2.4 Cell therapies, maket size and forecast 5.5.1.1 Blood glucose monitoring devices, maket size and forecast 5.5.1.2 Other dibetes testing devices, maket size and forecast 5.5.1.3 Software programs for diabetes monitoring, maket size and forecast 5.5.1.4 Artificial pancreas, maket size and forecast 5.5.2.1 Insulin, maket size and forecast 5.5.2.2 Insulin delivery, maket size and forecast 5.5.2.3 Oral hypoglycemic agents, maket size and forecast 5.5.2.4 Cell therapies, maket size and forecast 5.6.1.1 Blood glucose monitoring devices, maket size and forecast 5.6.1.2 Other dibetes testing devices, maket size and forecast 5.6.1.3 Software programs for diabetes monitoring, maket size and forecast 5.6.1.4 Artificial pancreas, maket size and forecast 5.6.2.1 Insulin, maket size and forecast 5.6.2.2 Insulin delivery, maket size and forecast 5.6.2.3 Oral hypoglycemic agents, maket size and forecast 5.6.2.4 Cell therapies, maket size and forecast To order this report:Drug_and_Medication Industry: Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018